FR2454623A1 - Procede de detection de fibrose kystique ou mucoviscidose - Google Patents

Procede de detection de fibrose kystique ou mucoviscidose

Info

Publication number
FR2454623A1
FR2454623A1 FR8008384A FR8008384A FR2454623A1 FR 2454623 A1 FR2454623 A1 FR 2454623A1 FR 8008384 A FR8008384 A FR 8008384A FR 8008384 A FR8008384 A FR 8008384A FR 2454623 A1 FR2454623 A1 FR 2454623A1
Authority
FR
France
Prior art keywords
detection
fibrosis
kystic
mucoviscidosis
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8008384A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of FR2454623A1 publication Critical patent/FR2454623A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Exchange Systems With Centralized Control (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

LA PRESENTE INVENTION A POUR OBJET UN PROCEDE DE DETECTION DE FIBROSE KYSTIQUE. ELLE EST CARACTERISEE EN CE QUE: A.ON PRELEVE SUR UN SUJET HUMAIN UN ECHANTILLON DE CELLULES CONTENANT DES MITOCHONDRIES, B.ON PREPARE UN HOMOGENAT DESDITES CELLULES, C.ON EFFECTUE UN TEST DE L'ACTIVITE DES MITOCHONDRIES DANS LES CELLULES, ET D.ON EVALUE LE TEST PAR COMPARAISON AVEC DES VALEURS DE REFERENCE ETABLIES DANS DES TESTS SEMBLABLES SUR D'AUTRES SUJETS DE CONDITION CONNUE. ELLE SE RAPPORTE AU DOMAINE DU DIAGNOSTIC MEDICAL.
FR8008384A 1979-04-16 1980-04-15 Procede de detection de fibrose kystique ou mucoviscidose Withdrawn FR2454623A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/030,179 US4273869A (en) 1979-04-16 1979-04-16 Cystic fibrosis detection method

Publications (1)

Publication Number Publication Date
FR2454623A1 true FR2454623A1 (fr) 1980-11-14

Family

ID=21852910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8008384A Withdrawn FR2454623A1 (fr) 1979-04-16 1980-04-15 Procede de detection de fibrose kystique ou mucoviscidose

Country Status (9)

Country Link
US (1) US4273869A (fr)
EP (2) EP0018202A1 (fr)
CA (1) CA1116501A (fr)
DK (1) DK458880A (fr)
FR (1) FR2454623A1 (fr)
NO (1) NO803726L (fr)
NZ (1) NZ193342A (fr)
WO (1) WO1980002294A1 (fr)
ZA (1) ZA802276B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036861A (en) * 1990-01-11 1991-08-06 Sembrowich Walter L Method and apparatus for non-invasively monitoring plasma glucose levels
US6183948B1 (en) 1998-04-15 2001-02-06 Johns Hopkins University Methods to identify compounds affecting mitochondria
GB0209812D0 (en) * 2002-04-30 2002-06-05 Renovo Ltd Genetic testing
ITMI20021148A1 (it) * 2002-05-28 2003-11-28 Univ Bologna Metodo per la determinazione della funzionalita' mitocondriale in cellule isolate e relativo kit
WO2020124152A1 (fr) * 2018-12-19 2020-06-25 Monash University Dosage pour le criblage de médicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899298A (en) * 1972-04-11 1975-08-12 Squibb & Sons Inc Method and apparatus for angiotensin i determination
US3867258A (en) * 1973-11-08 1975-02-18 American Cyanamid Co Lactate dehydrogenase test material
AT339505B (de) * 1974-03-14 1977-10-25 Boehringer Mannheim Gmbh Enzymatisches analysenverfahren
US4042462A (en) * 1975-12-24 1977-08-16 Monsanto Company Creatine phosphokinase determination method

Also Published As

Publication number Publication date
NO803726L (no) 1980-12-10
DK458880A (da) 1980-10-30
EP0027143A1 (fr) 1981-04-22
US4273869A (en) 1981-06-16
NZ193342A (en) 1982-09-14
EP0018202A1 (fr) 1980-10-29
CA1116501A (fr) 1982-01-19
ZA802276B (en) 1981-04-29
WO1980002294A1 (fr) 1980-10-30

Similar Documents

Publication Publication Date Title
FR2454623A1 (fr) Procede de detection de fibrose kystique ou mucoviscidose
Raczyńska et al. Diagnostic value of adenosine deaminase in some liver diseases
SU1013853A1 (ru) Способ определени воспалительного процесса в организме
Conradi et al. Cytotoxic activity in the plasma of amyotrophic lateral sclerosis (ALS) patients against normal erythrocytes: quantitative determinations
SU1127571A1 (ru) Способ дифференциальной диагностики эссенциальной и симптоматической гипертонии
SU942690A1 (ru) Способ диагностики интоксикации сол ми стронци
SU1702317A1 (ru) Способ определени инсулина в эритроцитах
SU1608462A1 (ru) Способ диагностики неспецифической диабетической нефропатии
SU1274682A1 (ru) Способ диагностики сальмонеллеза у детей
SU1409942A1 (ru) Способ диагностики псориаза
SU1175442A1 (ru) Способ диагностики гипоксии мозга у новорожденных
SU1627988A1 (ru) Способ диагностики патологии сердечно-сосудистой системы или хронической почечной недостаточности
SU800878A1 (ru) Способ диагностики активногодЕСТРуКТиВНОгО пРОцЕССА B ТКАН ХМОчЕВыВОд щиХ пуТЕй
SU1711076A1 (ru) Способ диагностики гепатита
SU765737A1 (ru) Способ определени гиперчувствительности к химическим аллергенам
RU2138809C1 (ru) Способ оценки функционального состояния циркулирующих нейтрофилов у человека
SU1617382A1 (ru) Способ дифференциальной диагностики туберкулеза и острой пневмонии
SU1179999A1 (ru) Способ диагностики синдрома Ирвин-Гасса
Tio et al. Changes in the serum transaminases in patients with syphilis.
SU1018015A1 (ru) Способ определени токсичности сыворотки крови
SU971265A1 (ru) Способ диагностики шока
SU1561038A1 (ru) Способ диагностики ревматического миокардита
Ferrone et al. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH‐like red cells
SU689664A1 (ru) Способ диагностики миокардита
SU1105189A1 (ru) Способ диагностики атопии

Legal Events

Date Code Title Description
ST Notification of lapse